Abeona Therapeutics, Inc. (ABEO)
5.36
-0.09
(-1.65%)
USD |
NASDAQ |
Jun 10, 16:00
5.355
0.00 (0.00%)
Pre-Market: 20:00
Abeona Therapeutics Debt to Equity Ratio : 0.1599 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1599 |
| December 31, 2025 | 0.1568 |
| September 30, 2025 | 0.1408 |
| June 30, 2025 | 0.1472 |
| March 31, 2025 | 0.5792 |
| December 31, 2024 | 0.5234 |
| September 30, 2024 | 0.5049 |
| June 30, 2024 | 0.3163 |
| March 31, 2024 | -2.609 |
| December 31, 2023 | 0.3642 |
| September 30, 2023 | 0.2583 |
| June 30, 2023 | 0.6393 |
| March 31, 2023 | 0.3906 |
| December 31, 2022 | 0.285 |
| September 30, 2022 | 0.5381 |
| June 30, 2022 | 0.4249 |
| March 31, 2022 | 0.2893 |
| December 31, 2021 | 0.1825 |
| September 30, 2021 | 0.0773 |
| June 30, 2021 | 0.0975 |
| March 31, 2021 | 0.0897 |
| December 31, 2020 | 0.0851 |
| September 30, 2020 | 0.078 |
| June 30, 2020 | 0.0763 |
| March 31, 2020 | 0.0583 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0446 |
| September 30, 2019 | 0.0851 |
| June 30, 2019 | 0.0784 |
| March 31, 2019 | 0.0732 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.0831 |
| September 30, 2014 | -0.0082 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Corcept Therapeutics, Inc. | 0.0151 |
| Forum Markets, Inc. | 0.161 |
| Precigen, Inc. | 4.855 |
| PDS Biotechnology Corp. | 4.075 |
| ACADIA Pharmaceuticals, Inc. | 0.0407 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 198.49M |
| Total Liabilities (Quarterly) | 53.56M |
| Shareholders Equity (Quarterly) | 144.94M |
| Current Ratio | 5.894 |
| Net Debt Paydown Yield | -0.01% |